Alterome Therapeutics, Inc. — Form D

Alterome Therapeutics, Inc. of SAN MARCOS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-14. The offering totals $63.8M, of which $63.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-01-14
• Form: D
• Accession: 0001904936-22-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $63.8M
• Amount sold: $63.8M
• Investors: 9
• Date of first sale: 2021-12-31
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-429619

Issuer

• Name: Alterome Therapeutics, Inc.
• CIK: 0001904936
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 727 VIA CAFETAL, SAN MARCOS, CA, 92069
• Phone: 650-493-9300

Officers, directors & promoters (8)

More

• CIK 1904936 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search